Darunavir "Accord" 150 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

darunavir "accord" 150 mg filmovertrukne tabletter

accord healthcare b.v. - darunavirpropylenglycolat - filmovertrukne tabletter - 150 mg

Darunavir "Accord" 300 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

darunavir "accord" 300 mg filmovertrukne tabletter

accord healthcare b.v. - darunavirpropylenglycolat - filmovertrukne tabletter - 300 mg

Darunavir "Accord" 600 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

darunavir "accord" 600 mg filmovertrukne tabletter

accord healthcare b.v. - darunavirpropylenglycolat - filmovertrukne tabletter - 600 mg

Darunavir "Accord" 800 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

darunavir "accord" 800 mg filmovertrukne tabletter

accord healthcare b.v. - darunavirpropylenglycolat - filmovertrukne tabletter - 800 mg

Epclusa Den Europæiske Union - dansk - EMA (European Medicines Agency)

epclusa

gilead sciences ireland uc - sofosbuvir, velpatasvir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 og 5.

Harvoni Den Europæiske Union - dansk - EMA (European Medicines Agency)

harvoni

gilead sciences ireland uc - ledipasvir, sofosbuvir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. for at hepatitis c virus (hcv) genotype-specifikke aktivitet, se afsnit 4. 4 og 5.

Vosevi Den Europæiske Union - dansk - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitis c kronisk - antivirale midler til systemisk anvendelse - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (se afsnit 4. 2, 4. 4 og 5.

Rukobia Den Europæiske Union - dansk - EMA (European Medicines Agency)

rukobia

viiv healthcare b.v. - fostemsavir trometamol - hiv infektioner - antivirale midler til systemisk anvendelse - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Vitekta Den Europæiske Union - dansk - EMA (European Medicines Agency)

vitekta

gilead sciences international ltd - elvitegravir - hiv infektioner - antivirale midler til systemisk anvendelse - vitekta co administreres med en ritonavir-boostet protease hæmmer og med andre antiretrovirale stoffer, er indiceret til behandling af human immundefekt virus 1 (hiv-1) infektion hos voksne, der er smittet med hiv-1 uden kendte mutationer forbundet med modstand mod elvitegravir.

Zepatier Den Europæiske Union - dansk - EMA (European Medicines Agency)

zepatier

merck sharp & dohme b.v. - elbasvir, grazoprevir - hepatitis c kronisk - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 og 5. for at hepatitis c virus (hcv) genotype-specifikke aktivitet, se afsnit 4. 4 og 5.